GEN Edge - Latest

Latest

All

GEN Edge

Green Shoots: Invaio Sciences Saves Orange Crops with Targeted Intravascular Delivery Technology

Bioprocessing

New President True to Aldevron’s Core

Artificial Intelligence

CZI to Build Massive GPU Cluster for Decoding Biology with AI

Drug Discovery

Conscious Re-Coupling: M&A Comes Back Surely, If Slowly

Drug Discovery

After Mod 2.0, What Can Be Done to Boost Adoption of Alternatives to Animal Models?

Bioprocessing

BPI News: Primrose Bio Blossoms from Pelican and Primordial Genetics Merger

Drug Discovery

StockWatch: Abcam Founder Opposes $5.7B Danaher Acquisition

Drug Discovery

Can CRISPR Crack the Code to Treating HIV Infections?

Artificial Intelligence

Generate:Biomedicines Raises Largest Biotech Series C of 2023

Artificial Intelligence

Chemify to Dream Up and Deliver Drugs for Dewpoint Therapeutics

Drug Discovery

Lights, Camera: Actio Biosciences Launches to Bridge Common and Rare Disease Treatments

Artificial Intelligence

Shuttle Launch: Cellares’ Smart Factories Aim to Meet Cell Therapy Demand at Global Scale

Artificial Intelligence

Superluminal Medicines Launches to Drug Protein Conformations in a Flash

OMICs

StockWatch: Investors, Analysts Debate Background of New Illumina CEO

OMICs

StockWatch: Despite 3-Week Decline, PacBio Stock Doubles in a Year

Close to the Edge

Perfect Pitch: Genome Editing Pioneer Fyodor Urnov on Commercializing CRISPR Therapies and Epigenomic Tuning

GEN Edge

Lessons from the Minimal Cell

Artificial Intelligence

Schrödinger’s Equation: Physics + Machine Learning = Drug Discovery

OMICs

StockWatch: Illumina Results Leave Investors, Analysts Anxious

Drug Discovery

StockWatch: Regeneron’s All Ears for Hearing Loss Drug Developer

Artificial Intelligence

Ordaōs Uses AI to Generate Therapeutic Mini-Proteins

Genome Editing

Frequency Change: Korro Bio Edits Its Message, Rewrites Its Future with Reverse Merger

Drug Discovery

Solu Therapeutics Launches with $31 Million to Unlock Cell-Surface Targets

Drug Discovery

StockWatch: Apellis Shares Nosedive 73% on Safety Concerns

Summits

The State of Biotech 2023

Drug Discovery

StockWatch: Layoffs Extend Biogen’s Stock Skid

Drug Discovery

Trier Bryant Pairs 82VS with Alloy to Create Asset-Centric Companies

OMICs

StockWatch: Quantum-Si Surges 47% as ARK Raises Its Stake

Artificial Intelligence

StockWatch: After $50M from Nvidia, Investors Bullish on Recursion

Artificial Intelligence

Boston Calling: Genomenon Acquires Boston Genetics for Rapid Human Genome Curation